OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Soluble epoxide hydrolase inhibitor, TPPU, increases regulatory T cells pathway in an arthritis model
Carlos Antônio Trindade‐da‐Silva, Juliana Trindade Clemente‐Napimoga, Henrique Ballassini Abdalla, et al.
The FASEB Journal (2020) Vol. 34, Iss. 7, pp. 9074-9086
Open Access | Times Cited: 26

Showing 1-25 of 26 citing articles:

Enhancing cancer immunotherapy via inhibition of soluble epoxide hydrolase
Abigail G. Kelly, Weicang Wang, Eva Rothenberger, et al.
Proceedings of the National Academy of Sciences (2024) Vol. 121, Iss. 7
Open Access | Times Cited: 11

The Multifaceted Role of Epoxide Hydrolases in Human Health and Disease
Jérémie Gautheron, Isabelle Jéru
International Journal of Molecular Sciences (2020) Vol. 22, Iss. 1, pp. 13-13
Open Access | Times Cited: 67

CYP450 Epoxygenase Metabolites, Epoxyeicosatrienoic Acids, as Novel Anti-Inflammatory Mediators
Zeqi Shi, Zuowen He, Dao Wen Wang
Molecules (2022) Vol. 27, Iss. 12, pp. 3873-3873
Open Access | Times Cited: 32

Soluble epoxide hydrolase inhibition enhances production of specialized pro‐resolving lipid mediator and promotes macrophage plasticity
Henrique Ballassini Abdalla, Carla Álvarez, Yu‐Chiao Wu, et al.
British Journal of Pharmacology (2022) Vol. 180, Iss. 12, pp. 1597-1615
Open Access | Times Cited: 21

Inhibiting Soluble Epoxide Hydrolase Suppresses NF-κB p65 Signaling and Reduces CXCL10 Expression as a Potential Therapeutic Target in Hashimoto's Thyroiditis
Jing Feng, Xianghong Xu, Wei Cai, et al.
The Journal of Clinical Endocrinology & Metabolism (2024)
Closed Access | Times Cited: 4

Discovery of Phenylacylpiperidine as Novel sEH Inhibitors through Scaffold Hopping of Natural Stilbene
Jing Ding, Minzhen Zhu, Xiaoyu Du, et al.
Journal of Medicinal Chemistry (2025)
Closed Access

From Inflammation to Resolution: Specialized Pro-resolving Mediators in Posttraumatic Osteoarthritis
Chilan B.G. Leite, Gergő Merkely, Julia F. Charles, et al.
Current Osteoporosis Reports (2023) Vol. 21, Iss. 6, pp. 758-770
Closed Access | Times Cited: 8

Design, Synthesis, and Pharmacological Characterization of a Potent Soluble Epoxide Hydrolase Inhibitor for the Treatment of Acute Pancreatitis
Simona Musella, Danilo D’Avino, Lukas K. Peltner, et al.
Journal of Medicinal Chemistry (2023) Vol. 66, Iss. 13, pp. 9201-9222
Open Access | Times Cited: 7

Modulating the sEH/EETs Axis Restrains Specialized Proresolving Mediator Impairment and Regulates T Cell Imbalance in Experimental Periodontitis
Henrique Ballassini Abdalla, Luciano Eduardo PUHL, Carla Alvarez Rivas, et al.
The Journal of Immunology (2023) Vol. 212, Iss. 3, pp. 433-445
Closed Access | Times Cited: 7

Peripheral soluble epoxide hydrolase inhibition reduces hypernociception and inflammation in albumin-induced arthritis in temporomandibular joint of rats
Juliana Maia Teixeira, Henrique Ballassini Abdalla, Rosanna Tarkany Basting, et al.
International Immunopharmacology (2020) Vol. 87, pp. 106841-106841
Open Access | Times Cited: 20

Peroxisome proliferator-activated receptor-gamma (PPARγ) and its immunomodulation function: current understanding and future therapeutic implications
Carlos Antônio Trindade‐da‐Silva, Juliana Trindade Clemente‐Napimoga, Henrique Ballassini Abdalla, et al.
Expert Review of Clinical Pharmacology (2022) Vol. 15, Iss. 3, pp. 295-303
Closed Access | Times Cited: 7

Chronic exposure to traffic-related air pollution reduces lipid mediators of linoleic acid and soluble epoxide hydrolase in serum of female rats
Nuanyi Liang, Shiva Emami, Kelley T. Patten, et al.
Environmental Toxicology and Pharmacology (2022) Vol. 93, pp. 103875-103875
Open Access | Times Cited: 6

Soluble epoxide hydrolase inhibition avoid formalin-induced inflammatory hyperalgesia in the temporomandibular joint
Henrique Ballassini Abdalla, Marcelo Henrique Napimoga, Juliana Maia Teixeira, et al.
Inflammopharmacology (2022) Vol. 30, Iss. 3, pp. 981-990
Open Access | Times Cited: 5

The impact of the soluble epoxide hydrolase cascade on periodontal tissues
Henrique Ballassini Abdalla, Thomas E. Van Dyke
Frontiers in Dental Medicine (2023) Vol. 4
Open Access | Times Cited: 2

Eicosanoid profiles in an arthritis model: Effects of a soluble epoxide hydrolase inhibitor
Carlos Antônio Trindade‐da‐Silva, Jun Yang, Flavia Fonseca, et al.
Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids (2023) Vol. 1869, Iss. 2, pp. 159432-159432
Open Access | Times Cited: 2

Sex-Specific Differences in Resolution of Airway Inflammation in Fat-1 Transgenic Mice Following Repetitive Agricultural Dust Exposure
Arzu Ulu, Jalene V. Velazquez, Abigail Burr, et al.
Frontiers in Pharmacology (2022) Vol. 12
Open Access | Times Cited: 4

Soluble epoxide hydrolase inhibition impairs triggering receptor expressed on myeloid cells‐1 in periodontal tissue
Breno da Silva Vargas, Bruno Sérgio Ferreira Vargas, Juliana Trindade Clemente‐Napimoga, et al.
Journal of Periodontal Research (2024)
Closed Access

Soluble epoxide hydrolase inhibitors for smoking-associated inflammatory lung diseases and chronic obstructive pulmonary disease: a meta-analytical systematic review of preclinical and clinical studies.
Felipe Alberto, Camila Botelho Miguel, Ana Paula Lazarin Bernardes, et al.
PubMed (2023) Vol. 15, Iss. 11, pp. 6649-6659
Closed Access | Times Cited: 1

Soluble epoxide hydrolase inhibitor blockage microglial cell activation in subnucleus caudalis in a persistent model of arthritis
Rosanna Tarkany Basting, Marcelo Henrique Napimoga, Carlos Antônio Trindade‐da‐Silva, et al.
International Immunopharmacology (2023) Vol. 120, pp. 110320-110320
Closed Access

Page 1 - Next Page

Scroll to top